Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Total Liabilities (2017 - 2021)

Cogent Biosciences has reported Total Liabilities over the past 5 years, most recently at $18.1 million for Q3 2021.

  • Quarterly results put Total Liabilities at $18.1 million for Q3 2021, down 23.79% from a year ago — trailing twelve months through Sep 2021 was $18.1 million (down 23.79% YoY), and the annual figure for FY2020 was $16.2 million, down 8.0%.
  • Total Liabilities for Q3 2021 was $18.1 million at Cogent Biosciences, up from $15.7 million in the prior quarter.
  • Over the last five years, Total Liabilities for COGT hit a ceiling of $32.0 million in Q1 2019 and a floor of $10.8 million in Q1 2021.
  • Median Total Liabilities over the past 5 years was $22.3 million (2017), compared with a mean of $21.6 million.
  • Biggest five-year swings in Total Liabilities: tumbled 60.02% in 2020 and later skyrocketed 32.99% in 2021.
  • Cogent Biosciences' Total Liabilities stood at $20.8 million in 2017, then rose by 23.46% to $25.7 million in 2018, then crashed by 31.26% to $17.7 million in 2019, then dropped by 8.0% to $16.2 million in 2020, then increased by 11.68% to $18.1 million in 2021.
  • The last three reported values for Total Liabilities were $18.1 million (Q3 2021), $15.7 million (Q2 2021), and $10.8 million (Q1 2021) per Business Quant data.